Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 454 across all filing types
Latest filing 2021-08-16 Share Issue/Capital Cha…
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Cleansing Notice 2 pages 221.1KB
Share Issue/Capital Change Classification · 95% confidence The document is an ASX announcement titled 'Cleansing Notice' pursuant to paragraph 708A(5)(e) of the Corporations Act 2001. It notifies the market about the issue of fully paid ordinary shares without disclosure under Part 6D.2 of the Corporations Act and confirms compliance with relevant sections of the Act. The document is short (4057 characters) and serves as a formal notice related to share issuance and compliance, rather than a full financial report or detailed analysis. It does not contain financial statements or substantive financial data. This type of announcement fits best under the category of Share Issue/Capital Change (SHA), as it relates to the issuance and quotation of new shares and compliance notices associated with that.
2021-08-16 English
Quarterly Activities Report & Appendix 4C 12 pages 1.1MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'JUNE 2021 QUARTERLY ACTIVITIES REPORT AND APPENDIX 4C' and contains detailed operational and financial information for the quarter ending 30 June 2021. It includes financial highlights, cash receipts, acquisition details, patient growth, and other substantive financial and business data. The length is approximately 15,000 characters, indicating a comprehensive report rather than a brief announcement. The content aligns with a quarterly report providing actual financial data and business updates for a period shorter than a full fiscal year. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q4 2021
2021-07-27 English
Results of Meeting 2 pages 273.4KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'RESULTS OF GENERAL MEETING' and provides detailed voting results for resolutions passed at a general meeting held on 19 July 2021. It includes poll results with votes for, against, and abstain for multiple resolutions. The document is an announcement of the voting outcomes from a shareholder meeting, not the meeting materials themselves or a report. It matches the description of 'Declaration of Voting Results & Voting Rights Announcements (DVA)', which covers official results from shareholder votes at any general meeting. The document length is short (1798 characters), consistent with a voting results announcement rather than a full report or presentation.
2021-07-18 English
Change in substantial holding 2 pages 288.6KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001. It details changes in voting power and relevant interests of a substantial shareholder (Elixxir Ltd) in Little Green Pharma Ltd. The content focuses on shareholding notifications and changes in substantial ownership percentages. There are no financial statements, management commentary, or other report types present. This matches the definition of Major Shareholding Notification (MRQ). The document length is short and specific to shareholding changes, confirming MRQ classification.
2021-07-06 English
Investor Webinar - Denmark Acquisition 1 page 221.4
Investor Presentation Classification · 95% confidence The document is an ASX announcement dated 6 July 2021 about an investor webinar related to the company's recent acquisition of medicinal cannabis facilities in Denmark. It provides a link to the webinar recording and contact information but does not contain detailed financial data, report content, or regulatory filings. The document is short (1097 characters) and serves as an announcement of an event (investor webinar) rather than a full report or detailed financial disclosure. Therefore, it fits best as an Investor Presentation (IP) category, as it focuses on providing additional background and context to investors through a presentation format.
2021-07-05 English
Becoming a substantial holder 3 pages 181.3KB
Regulatory Filings Classification · 90% confidence The document contains only placeholders for pictures and no textual content or financial data. The length is very short (336 characters) and there is no indication of any report or announcement content. It does not contain any report, announcement, or certification. Given the lack of substantive content, this document does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category.
2021-07-05 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.